Cargando…
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users: A position statement on the use of bioresorbable vascular scaffolds in the Netherlands
Percutaneous coronary interventions (PCI) have become a reliable revascularisation option to treat ischaemic coronary artery disease. Drug-eluting stents (DES) are widely used as first choice devices in many procedures due to their established good medium to long term outcomes. These permanent impla...
Autores principales: | Everaert, Bert, Felix, Cordula, Koolen, Jacques, den Heijer, Peter, Henriques, Jose, Wykrzykowska, Joanna, van der Schaaf, Rene, de Smet, Bart, Hofma, Sjoerd, Diletti, Roberto, Van Mieghem, Nicolas, Regar, Evelyn, Smits, Peter, van Geuns, Robert-Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352153/ https://www.ncbi.nlm.nih.gov/pubmed/25626696 http://dx.doi.org/10.1007/s12471-015-0651-3 |
Ejemplares similares
-
Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions: 2017 revision
por: Everaert, B., et al.
Publicado: (2017) -
Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions
por: Felix, Cordula, et al.
Publicado: (2015) -
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017) -
Angiographic and Optical Coherence Tomography Insights Into Bioresorbable Scaffold Thrombosis: Single-Center Experience
por: Karanasos, Antonios, et al.
Publicado: (2015) -
Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
por: Karanasos, Antonios, et al.
Publicado: (2014)